<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Clinical Oncology</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/1B52B94A-9456-4176-B6D1-1A4415548D28"><gtr:id>1B52B94A-9456-4176-B6D1-1A4415548D28</gtr:id><gtr:firstName>Anna</gtr:firstName><gtr:surname>Philpott</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0500101"><gtr:id>F0C3ECA7-737E-4087-A5CC-61C3FD92BDF3</gtr:id><gtr:title>Division versus differentiation: cell cycle regulation of proneural protein stability</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0500101</gtr:grantReference><gtr:abstractText>Cells in the early embryonic nervous system divide very rapidly, but it is also vital that these cells know when to stop dividing and turn into mature nerves, a process known as differentiation. At present, we have a poor understanding of how the balance between division and differentiation is controlled, and this is what we aim to investigate in this proposal. The protein Neurogenin promotes differentiation of neurons. However, when cells are rapidly dividing, we have shown that this protein is quickly destroyed. In this proposal, we will investigate the molecular mechanism of Neurogenin protein destruction and how proteins that control cell division regulate this process. To this end we will use very young tadpole embryos, which have a nervous system very similar to mammals, but which develop outside the mother and are readily available as an experimental model. The experiments proposed will enable us to design a Neurogenin protein that cannot be destroyed. We will introduce this protein back into the early frog tadpole to investigate effects on development of the embryonic nervous system.
 These studies are designed to lead to three potential long-term health benefits. Firstly, a greater understanding of how the embryonic nervous system forms may help with management, treatment and prevention of neural defects in human embryos. Secondly, results from this study may allow us to design ways to promote production of nerves from stem cells, for treatment of nervous system damage such as spinal cord injury and stroke. Thirdly, these studies may help us to design treatments to reduce malignancy of brain tumours and other nervous system cancers, many of which are amongst the hardest cancers to treat.</gtr:abstractText><gtr:technicalSummary>The correct balance between division and differentiation is essential for tissue and organ formation both during development and during stem cell-mediated tissue regeneration. Moreover, this balance is altered in essentially all cancers. Therefore, an understanding of the molecular mechanisms co-ordinating division and differentiation is of fundamental importance, although at present this area is poorly understood. To this end, we are studying the cell-cycle-mediated regulation of differentiation using neurogenesis in the Xenopus frog embryo as a model system. 
 Proneural basic-heix-loop-helix transcription factors such as Neurogenin (NGN) drive the specification and differentiation of neurons and glia. We have shown that NGN activity is controlled directly by cell cycle regulators such as cdks and cdk inhibitors. Here we present preliminary data suggesting NGN is degraded by Ub-mediated proteolysis and that this degradation is controlled by cell cycle regulators. Using Xenopus eggs, embryos and extracts thereof, this project aims to confirm these findings, to investigate at a molecular level how NGN is targeted for degradation and to determine how cell cycle components influence this process.</gtr:technicalSummary><gtr:fund><gtr:end>2008-11-13</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-11-14</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>214390</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC National Institute for Medical Research (NIMR)</gtr:department><gtr:description>Testing cdk inhibitor-dependent regulation of NGN2</gtr:description><gtr:id>1D757F4E-2098-4622-A6C4-A6C8BF1FAD95</gtr:id><gtr:impact>Ongoing collaboration with 3 subsequent joint grant applications, exchange of reagents, visits from students in my lab to NIMR to learn new techniques.</gtr:impact><gtr:partnerContribution>They can use mammalian systems to confirm findings we have in the Xenopus model system. We have free transfer of reagents and expertise between the two groups.</gtr:partnerContribution><gtr:piContribution>The NIMR group used our unpublished findings in frog to design experiments in mice demonstrating that NGN2 stability is regulated by cdk inhibitors in the same way in both model systems.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Harvard Medical School</gtr:department><gtr:description>In vitro assays for cdk phosphorylation</gtr:description><gtr:id>992820A3-8385-4F54-99F4-323E019B2111</gtr:id><gtr:impact>Primary research publication.</gtr:impact><gtr:partnerContribution>Undertook biochemical analysis of our mutanats, providing crucial data for a co-authored publication.</gtr:partnerContribution><gtr:piContribution>We provided conceptual ideas and experimental materials</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC National Institute for Medical Research (NIMR)</gtr:department><gtr:description>Post-translational modification of proneural proteins</gtr:description><gtr:id>4F850A40-DD9D-482B-BACC-821D225DD5AF</gtr:id><gtr:impact>We have submitted a joint grant application (unsuccessful) and have published a co-authored primary publication.</gtr:impact><gtr:partnerContribution>My collaborator is using our data generated in Xenopus to extrapolate to the developing mouse and we are currently preparing two co-authored publications.</gtr:partnerContribution><gtr:piContribution>We provided experimental data from Xenopus and cultured cells and crucial conceptual imputs.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Research Grant</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>57F95AD5-6ADB-4495-9BCC-0CA05AF04297</gtr:id><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>using kinase inhibitors, we can enhance the ability of bHLH transcription factors to drive differentiation in a number of tissues including neutrons and pancreatic islets. This is useful for disease modelling and has the potential to improve generation of pancreatic islets for transplantation.</gtr:description><gtr:id>7AEC5F51-CC4B-48C8-AF86-033A292FDE24</gtr:id><gtr:impact>None yet, although the methodology is in development in my lab still.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:patentId>PCT/EP2013/068511</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>maturation of mammalian cells by modulation of protein phosphorylation</gtr:title><gtr:yearProtectionGranted>2013</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>New assay methods for Ubiquitin-mediated proteolysis in Xenopus eggs and embryos</gtr:description><gtr:id>B10200E6-81D1-43EE-B4CF-5BCA75733D53</gtr:id><gtr:impact>fast screening of the degradation of proteins and modified proteins to look at stability/unfoldability rapidly, looking at both canonical and novel non-canonical modes of ubiquitination.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Cysteine ubiquitination assay</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2F442F85-6101-4FC3-96E7-A39941E96644"><gtr:id>2F442F85-6101-4FC3-96E7-A39941E96644</gtr:id><gtr:title>p27kip1 independently promotes neuronal differentiation and migration in the cerebral cortex.</gtr:title><gtr:parentPublicationTitle>Genes &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bde87606bcc5c3567a12bd3b0dfaa8ce"><gtr:id>bde87606bcc5c3567a12bd3b0dfaa8ce</gtr:id><gtr:otherNames>Nguyen L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0890-9369</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F0CD8222-0892-4DC8-B451-43581A8F32EB"><gtr:id>F0CD8222-0892-4DC8-B451-43581A8F32EB</gtr:id><gtr:title>The F-box protein Cdc4/Fbxw7 is a novel regulator of neural crest development in Xenopus laevis.</gtr:title><gtr:parentPublicationTitle>Neural development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/324714ef032f0bb8bfd33fa8127cf417"><gtr:id>324714ef032f0bb8bfd33fa8127cf417</gtr:id><gtr:otherNames>Almeida AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1749-8104</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7E966FE9-4B3B-4315-9858-B3B367D07C50"><gtr:id>7E966FE9-4B3B-4315-9858-B3B367D07C50</gtr:id><gtr:title>Regulation of neurogenin stability by ubiquitin-mediated proteolysis.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/376c687cf44bb401ebcfab6c62dac9ea"><gtr:id>376c687cf44bb401ebcfab6c62dac9ea</gtr:id><gtr:otherNames>Vosper JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/07A29F41-E80C-4243-AB73-20DF4A3432AE"><gtr:id>07A29F41-E80C-4243-AB73-20DF4A3432AE</gtr:id><gtr:title>An oncologist?s friend: How Xenopus contributes to cancer research.</gtr:title><gtr:parentPublicationTitle>Developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3e3bd53c935f643aab5b8c97e7f6e3f0"><gtr:id>3e3bd53c935f643aab5b8c97e7f6e3f0</gtr:id><gtr:otherNames>Hardwick LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0012-1606</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/69987160-1473-400E-A2AF-E79002D79414"><gtr:id>69987160-1473-400E-A2AF-E79002D79414</gtr:id><gtr:title>Complex regulation controls Neurogenin3 proteolysis.</gtr:title><gtr:parentPublicationTitle>Biology open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f26e929861b28361d5485614d97602e8"><gtr:id>f26e929861b28361d5485614d97602e8</gtr:id><gtr:otherNames>Roark R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2046-6390</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/51BBEBE7-932E-4EAC-BA8D-C86154A2EF84"><gtr:id>51BBEBE7-932E-4EAC-BA8D-C86154A2EF84</gtr:id><gtr:title>The F-box protein Cdc4/Fbxw7 is a novel regulator of neural crest development in Xenopus laevis.</gtr:title><gtr:parentPublicationTitle>Neural development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/324714ef032f0bb8bfd33fa8127cf417"><gtr:id>324714ef032f0bb8bfd33fa8127cf417</gtr:id><gtr:otherNames>Almeida AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1749-8104</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0500101</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>